Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

about

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration.Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation.Application of Metabolomics in the Study of Natural Products

P2860

Q52606206-8F041D87-ACF7-4846-8BDD-B105B34390E9 Q52661291-9AEFE2C4-62CF-4E25-9A2C-A5F485AEE6A8 Q57173224-6F74F4A1-257E-4242-B776-C219793E3018

P2860

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

Item

http://www.wikidata.org/entity/Q41114295

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

@en

type

Item

label

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

@en

prefLabel

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

@en

P1476

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

@en

P2093

Bao-Ying Wen

http://www.w3.org/2001/XMLSchema#string

Chi-Yu He

http://www.w3.org/2001/XMLSchema#string

Fang Guo

http://www.w3.org/2001/XMLSchema#string

Jia-Wen Shou

http://www.w3.org/2001/XMLSchema#string

Jian-Dong Jiang

http://www.w3.org/2001/XMLSchema#string

Jie Fu

http://www.w3.org/2001/XMLSchema#string

Qian Tong

http://www.w3.org/2001/XMLSchema#string

Shu-Rong Ma

http://www.w3.org/2001/XMLSchema#string

Xian-Feng Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Yang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Berberine improves glucose metabolism through induction of glycolysis

Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine

Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

Pharmacokinetics and oral bioavailability of epimedin C after oral administration of epimedin C and Herba Epimedii extract in rats.

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes.

Tissue distribution of berberine and its metabolites after oral administration in rats.

Biotransformation and in vitro metabolic profile of bioactive extracts from a traditional Miao-nationality herbal medicine, Polygonum capitatum.

Transforming berberine into its intestine-absorbable form by the gut microbiota

P304

2443-2451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/THNO.18290

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28744326

http://www.w3.org/2001/XMLSchema#string

P921

hyperlipidemia

P932

5525748

http://www.w3.org/2001/XMLSchema#string

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

about

P2860

P2860

Gut Microbiota-Mediated Personalized Treatment of Hyperlipidemia Using Berberine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932